The Graves’ Disease & Thyroid Foundation provides educational and support services for patients with Graves’ disease, thyroid eye disease & related disorders.
Joined October 2011
- Tweets 8,652
- Following 675
- Followers 6,120
- Likes 3,623
370 Photos and videos
Do you have questions about Graves' disease or thyroid eye disease? Join GDATF and @TheAAES on Wednesday, June 17th at 5 p.m. PDT / 8 p.m. EDT for a special webinar! Register using this link or the QR code in the graphic: us06web.zoom.us/webinar/regi…
ALT Head shots of webinar moderators & panelists Moderators: Dr. Alexander Chiu Dr. Iuliana Bobanga Panelists: Dr. Joyce Shin, Endocrine Surgeon, Cleveland Clinic Dr. Brenessa Lindeman, Endocrine Surgeon, University of Alabama Birmingham School of Medicine Dr. Jennifer Mammen, Endocrinologist, Johns Hopkins University School of Medicine Dr. Raymond Douglas, Oculoplastic Surgeon
1
1
94
Graves' Disease & Thyroid Foundation retweeted
Pleased to share the publication of the new ATA guideline for #thyroid disease in #pregnancy. It was a privilege to serve on the committee and work with an exceptional group of colleagues whose expertise and dedication made this important effort possible. @UAMSEndo @VAWomenVets
BREAKING - 2026 #ATA Guidelines for Thyroid Disease in Preconception, Pregnancy, and Postpartum released! 💡 Key highlights & discussion: ow.ly/V0JX50Z6iXM #ThyroidEducation @thyroidjournal @clinicalthyroid
1
6
728
This is a really powerful essay from actor Erin Moriarty on her long battle to get a diagnosis - and the lingering mental health impact of autoimmune diseases. time.com/article/2026/05/21/…
1
107
Graves' Disease & Thyroid Foundation retweeted
BREAKING - 2026 #ATA Guidelines for Thyroid Disease in Preconception, Pregnancy, and Postpartum released! 💡 Key highlights & discussion: ow.ly/V0JX50Z6iXM #ThyroidEducation @thyroidjournal @clinicalthyroid
18
26
2,723
Graves' Disease & Thyroid Foundation retweeted
Clinical trials are carefully reviewed and monitored to protect participants. Safety is a priority at every stage, with strict guidelines in place.
Get the facts about clinical trials in our latest blog: autoimmune.org/blog/autoimmu…
1
1
111
Graves' Disease & Thyroid Foundation retweeted
🌍Join Us in Celebrating #WorldThyroidDay2026 – May 25th! In 2008, May 25 was officially designated as #WorldThyroidDay by the @ETA_Thyroid. Since 2010, it has been endorsed globally by organizations, including: @AmThyroidAssn, @LATS_Society & #AOTA. ow.ly/XAEW50Z3aje
7
13
935
Graves' Disease & Thyroid Foundation retweeted
Thyroid eye disease (#TED) affects every aspect of people’s lives, and the psychosocial toll is immense.
The insights from our ElevaTED patient survey reveal the critical need for comprehensive care and innovative solutions that address the full, multi-faceted impact of TED.
3
4
209
Graves' Disease & Thyroid Foundation retweeted
🗓️Last Chance to Register for 5/18 ATA® Alliance for Thyroid Patient Education Forum. Please share with your patients & colleagues - it's a great opportunity for patients to connect! Save Your Spot Now! ow.ly/vZyf50Z0ptJ #ThyroidAwareness #PatientEducation #ThyroidHealth
2
4
364
This might be of interest to our patient community, given that some patients with autoimmune thyroid disease also have PMOS (previously known as PCOS).
PCOS has a new name: Polyendocrine Metabolic Ovarian Syndrome (PMOS). With 50 patient and professional groups, we helped develop a name that better reflects a condition affecting 1 in 8 women worldwide. Learn more: bit.ly/3Rgydi3 #PMOS #PCOS
1
3
187
Graves' Disease & Thyroid Foundation retweeted
The challenges of #ThyroidEyeDisease (#TED) extend far beyond the surface.
The ElevaTED survey gathered insights from more than 200 people living with TED and revealed the extensive hidden challenges people face.
At Viridian, we are committed to making a meaningful difference.
3
3
176
Check out this insightful read from Medscape News Canada on AI and medical misinformation. (Login might be required to view, but registration should be free.) medscape.com/viewarticle/mis…
ALT “People…shouldn’t replace a conversation with a healthcare professional who knows their situation. If something you read online changes your mind about a treatment, that’s exactly the moment to discuss it with your doctor, not act on it alone.”
1
1
98
Graves' Disease & Thyroid Foundation retweeted
Today we announced positive topline results from our pivotal phase 3 REVEAL-2 clinical trial which evaluated elegrobart in chronic thyroid eye disease (TED).
Learn more: investors.viridiantherapeuti…
2
3
143
Graves' Disease & Thyroid Foundation retweeted
🦋 May is International Thyroid Awareness Month. The ATA® offers 50 #thyroid brochures for all. 📢 Share and refer patients & colleagues to ow.ly/mXqf50YTgCP #ThyroidEducation #InternationalThyroidAwarenessMonth #ThyroidHealth @thyroidjournal @clinicalthyroid
5
12
585
"I was on set every day just really, really, really struggling to get through it all." Erin Moriarty recently spoke to The Hollywood Reporter about filming "The Boys" after a diagnosis of Graves' disease. hollywoodreporter.com/tv/tv-…
1
172
Graves' Disease & Thyroid Foundation retweeted
We're headed to #AACE2026 this week! Our team will share data from our THRIVE and ElevaTED studies in #ThyroidEyeDisease. Visit us at booth # 093 to learn how we’re working to address unmet needs for patients with TED.
2
2
257
Graves' Disease & Thyroid Foundation retweeted
🗓️ Save the Date: ATA® Thyroid Patient Education Forum, May 18, 8-9:15 PM ET. Join us to connect with #thyroid experts and patients! Register free: ow.ly/QIKK50YMIeg #thyroid
1
3
391
If you are attending #AAES2026, today is the last day for the exhibit hall - stop by Ballroom 1 and say hello!
ALT Tabletop space with Graves' Disease & Thyroid Foundation logo and newsletters/brochures
1
3
105
Our blog post warning other patient organizations about WebinarTV was featured in this post from @404mediaco: 404media.co/webinartv-secret…
1
88
1/2 Amgen has announced positive topline results from a Phase 3 trial of TEPEZZA (TM) delivered via an on-body injector (OBI). Patients treated w/ TEPEZZA currently receive eight infusions delivered three weeks apart, but the Phase 3 OBI trial tested a... amgen.com/newsroom/press-rel…
1
1
168
2/2 ...regimen of 12 OBI injections, delivered two weeks apart. The trial met its primary endpoint in moderate-to-severe active TED, showing a 77% proptosis response over 24 weeks (versus 20% placebo).
1
93